Menu
The Biotechnology Agreement will contain terms for licensing of intellectual property developed by us.
Cymra will have an ongoing breeding program and regularly release new varieties which will be offered on a licensing and royalty program. Cymra’s intention is that the new varieties will have improved desirable characteristics such as disease/pest resistance, increased yield, increased agronomic efficiencies.
If you are a cultivator that would like to discuss our services, trial or purchase our genetics or purchase get in touch with us.
© 2021 Cymra Life Sciences – Vir Pharma Holdings – ABN 54 621 123 760
Want to keep up to date with the latest Medical Cannabis Information in Australia and from around the world? We will send you informative information from time to time so you can learn about cannabis and if it can help you.